Novel Synthetic (Poly)Glycerolphosphate-Based Antistaphylococcal Conjugate Vaccine

A Novel ICOS-Independent, but CD28- and SAP-Dependent, Pathway of T Cell-Dependent, Polysaccharide-Specific Humoral Immunity in Response to Intact Streptococcus pneumoniae versus Pneumococcal Conjugate Vaccine

(2014) Q. Chen et al.   JOURNAL OF IMMUNOLOGY

Mechanisms underlying in vivo polysaccharide-specific immunoglobulin responses to intact extracellular bacteria

(2012) Clifford M. Snapper   Annals of the New York Academy of Sciences

Light fluorous synthesis of glucosylated glycerol teichoic acids

(2012) W.F.J. Hogendorf et al.   CARBOHYDRATE RESEARCH

Development of a Fourfold Multiplexed Opsonophagocytosis Assay for Pneumococcal Antibodies against Additional Serotypes and Discovery of Serological Subtypes in Streptococcus pneumoniae Serotype 20

(2012) Robert L. Burton et al.   Clinical and Vaccine Immunology

Protection Against Staphylococcus aureus by Antibody to the Polyglycerolphosphate Backbone of Heterologous Lipoteichoic Acid

(2012) Christian Theilacker et al.   JOURNAL OF INFECTIOUS DISEASES

Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model

(2012) Amita Joshi et al.   Human Vaccines & Immunotherapeutics

What is the best way to use conjugate vaccines?

(2011) Anna Seale et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Murine Immune Response to a ChronicStaphylococcus aureusBiofilm Infection

(2011) Ranjani Prabhakara et al.   INFECTION AND IMMUNITY

Is there a future for a Staphylococcus aureus vaccine?

(2011) Richard A. Proctor   VACCINE

Synthesis of an α-kojibiosyl substituted glycerol teichoic acid hexamer

(2010) Wouter F.J. Hogendorf et al.   BIOORGANIC & MEDICINAL CHEMISTRY

High Levels of Antibody to Panton‐Valentine Leukocidin Are Not Associated with Resistance toStaphylococcus aureus–Associated Skin and Soft‐Tissue Infection

(2010) Christina R. Hermos et al.   CLINICAL INFECTIOUS DISEASES

Role of Interleukin-17A in Cell-Mediated Protection against Staphylococcus aureus Infection in Mice Immunized with the Fibrinogen-Binding Domain of Clumping Factor A

(2010) K. Narita et al.   INFECTION AND IMMUNITY

Targeting of Alpha‐Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model

(2010) Adam D. Kennedy et al.   JOURNAL OF INFECTIOUS DISEASES

Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses

(2009) Harumichi Ishigame et al.   IMMUNITY

Staphylococcal Vaccines and Immunotherapies

(2009) Adam C. Schaffer et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Staphylococcus aureus: A Community Pathogen

(2009) Loren G. Miller et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus

(2009) Guoqing Xia et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Presence of Genes Encoding the Panton-Valentine Leukocidin Exotoxin Is Not the Primary Determinant of Outcome in Patients with Complicated Skin and Skin Structure Infections Due to Methicillin-Resistant Staphylococcus aureus: Results of a Multinational Trial

(2009) I.-G. Bae et al.   JOURNAL OF CLINICAL MICROBIOLOGY

TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity

(2008) Ulrich Zähringer et al.   IMMUNOBIOLOGY

The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus

(2008) B. Spellberg et al.   INFECTION AND IMMUNITY

Vaccine protection againstStaphylococcus aureuspneumonia

(2008) Juliane Bubeck Wardenburg et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity

(2007) Dan Li et al.   JOURNAL OF ORTHOPAEDIC RESEARCH